WST West Pharmaceutical Services Inc
Company Analysis
Latest News
🟢 West Pharmaceutical Services is trading 4.65% up in pre-market after Q3 beat and raised full-year guidance
West Pharmaceutical Services is trading at $436.05, up 4.65% in pre-market after Q3 sales and adjusted EPS beat estimates and management raised guidance. -...
🟢 West Pharmaceutical Services is trading 5% up today after Q3 earnings beat and raised 2026 guidance
West Pharmaceutical Services is trading at $420.96, up 5.41%, after strong Q3 results and raised 2026 guidance. - On October 29, the company reported Q3 sales...
🟢 West Pharmaceutical Services is trading 6.5% up in pre-market after third-quarter beat and raised full-year guidance
West Pharmaceutical Services is trading at $430.00, +6.53%, in pre-market after its third-quarter earnings beat and raised full-year guidance. - On October...
West Pharmaceutical Services beats third quarter 2026 estimates and raises outlook on strong biologics demand
West Pharmaceutical Services delivered a robust performance in the third quarter of 2026, significantly exceeding analyst expectations for both top and...
West Pharmaceutical Services Inc Q3 2026 Earnings Preview: What Analysts Expect on October 29, 2026
West Pharmaceutical Services is expected to report Q3 2026 revenue of $827.12 million and earnings per share of $2.18, with the current stock price of $392.15...
Viking Global Exits $104.5M Position in West Pharmaceutical Services
Andreas Halvorsen's Viking Global Investors fully liquidated its stake in West Pharmaceutical Services (WST) during the second quarter of 2026. The sale...